2049-1941 Screening compound: 6-(1,3-benzodioxol-5-yl)-3-(butylsulfanyl)-6,7-dihydro[1,2,4]triazino[5,6-d][3,1]benzoxazepine

2049-1941 Screening compound: 6-(1,3-benzodioxol-5-yl)-3-(butylsulfanyl)-6,7-dihydro[1,2,4]triazino[5,6-d][3,1]benzoxazepine
2049-1941 Screening compound: 6-(1,3-benzodioxol-5-yl)-3-(butylsulfanyl)-6,7-dihydro[1,2,4]triazino[5,6-d][3,1]benzoxazepine alternative view

Chemical Structure Depiction of ChemDiv screening compound 2049-1941
6-(1,3-benzodioxol-5-yl)-3-(butylsulfanyl)-6,7-dihydro[1,2,4]triazino[5,6-d][3,1]benzoxazepine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

2049-1941

Molecular Formula

C21H20N4O3S (C21 H20 N4 O3 S)

Compound Name

6-(1,3-benzodioxol-5-yl)-3-(butylsulfanyl)-6,7-dihydro[1,2,4]triazino[5,6-d][3,1]benzoxazepine

IUPAC name

9-(2H-13-benzodioxol-5-yl)-5-(butylsulfanyl)-8-oxa-34610-tetraazatricyclo[9.4.0.0^{27}]pentadeca-1(11)2(7)351214-hexaene

SMILES

CCCCSc1nnc(-c(cccc2)c2NC(c(cc2)cc3c2OCO3)O2)c2n1

InChI

InChI=1S/C21H20N4O3S/c1-2-3-10-29-21-23-20-18(24-25-21)14-6-4-5-7-15(14)22-19(28-20)13-8-9-16-17(11-13)27-12-26-16/h4-9,11,19,22H,2-3,10,12H2,1H3/t19-/m0/s1

InChI Key

QPUXQTZXQLDKBO-IBGZPJMESA-N

MDL Number (MFCD)

MFCD01019243

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

408.48

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.977

Distribution Coefficient, logD

4.977

Water Solubility, LogSw

-4.63

Polar Surface Area

69.413

Acid Dissociation Constant (pKa)

18.19

Base Dissociation Constant (pKb)

5.72

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

28.57

2049-1941 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with 2049-1941 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 2049-1941?
Check Price and Availability of 2049-1941, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 2049-1941 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 2049-1941
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 2049-1941
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 2049-1941 available by request